.png)
.png)
MD
National Institute of Allergy and Infectious Disease
Disclosure(s): No financial relationships to disclose
Seher Anjum MD is a Staff Clinician within the Translational Mycology Section of the Laboratory of Clinical Immunology and Microbiology(LCIM) at NIAID, NIH. She obtained an MD from Kasturba Medical College, India in 2010 after which she completed an internal medicine residency at the University of Missouri, Kansas City followed by an Infectious Disease fellowship at the University of Texas Medical Branch in Galveston, TX. She is currently involved in performing clinical research to understand the pathogenesis and management of post-infectious inflammatory response syndrome (PIIRS) in previously healthy patients with cryptococcal infections. Her role includes investigating disease susceptibility in this population, clinical care and the use of corticosteroids and alternative steroid-sparing immunomodulatory agents in controlling neuro-inflammation as a result of PIIRS. She has also described ocular, neurocognitive and auditory defects related to cryptococcal meningitis in collaboration with NIMH, NIDCD and NEI. She attends on the LCIM ward service and Infectious Disease consult Service at the NIH Clinical Center was a member of the NIAID COVID-19 Outbreak Response Team in 2020. Future projects include conducting large-scale clinical trials as part of the CINCH (Cryptococcus Infection Network in non-HIV Cohort) to assess outcomes with corticosteroid use in HIV negative CM-PIIRS and the use of newer, oral antifungal agents in the treatment of cryptococcal infections. She is also an active member of the Mycosis Study Group Education and Research Group Consortium (MSGERC) and the Infectious Disease Society of America (IDSA).